NASDAQ · PPCB
Propanc Biopharma, Inc.
$1.93-$0.19 (-8.77%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
Loading market information…
OTC · NXNN · USD
Stock price, earnings
Quote as of Oct 29, 2024, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nexeon MedSystems Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nexeon MedSystems Inc. operates as a medical device enterprise, dedicated to the innovation, production, and market launch of neurostimulation solutions. These solutions leverage electrical impulses to modulate neural activity, offering therapeutic interventions for a spectrum of neurological conditions. Their robust neurostimulation platform is engineered to serve a wide array of neurostimulator applications, encompassing deep brain stimulation (DBS), peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, and vagus nerve stimulation, among other related fields. Among its key developments is the Viant, a Deep Brain Stimulation (DBS) system. This system is being advanced for Parkinson's disease treatment within the United States, while its European applications extend to cover Parkinson's disease, Essential Tremor, and Dystonia. Founded in 2015, Nexeon MedSystems Inc. maintains its operational base in Dallas, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:30 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$1.93-$0.19 (-8.77%)
Propanc Biopharma, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.4% below the high.
$0.00-$0.05 (-99.6%)
StatSure Diagnostic Systems, Inc.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Cell Kinetics Ltd.: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
PotNetwork Holdings, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Predictive Technology Group, Inc.: Healthcare · Biotechnology.
$0.00-$0.00 (-25.0%)
Invitae Corporation: Healthcare · Medical - Diagnostics & Research.
$0.00$0.00 (0.0%)
Health-Chem Corporation: Healthcare · Medical - Diagnostics & Research.
$0.00$0.00 (0.0%)
Clarus Therapeutics Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.96% below the high.
